PCRX
Pacira BioSciences, Inc. · Healthcare
Insiders sold $2.0M of Pacira BioSciences, Inc. in the last 12 months and bought none
PCRX over the last year
PCRX after insider buys
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
193 insider filings since 2016, newest first
Lauren Riker · Senior Vice President, Finance
Jonathan Slonin · Chief Medical Officer
Lauren Riker · Senior Vice President, Finance
Kristen Williams · Chief Administrative Officer
Shawn Cross · CFO
Shawn Cross · CFO
Jonathan Slonin · Chief Medical Officer
Lauren Riker · SVP, Finance
Shawn Cross · CFO
Michael J. Yang · Director
Frank D. Lee · CEO
Marcelo Bigal · Director
Jonathan Slonin · Chief Medical Officer
Lauren Riker · SVP, Finance
Jonathan Slonin · Chief Medical Officer
Daryl Gaugler · COO
Kristen Williams · Chief Administrative Officer
Gary W Pace · Director
Lauren Bullaro Riker · SVP, Finance
Lauren Bullaro Riker · SVP, Finance
Kristen Marie Williams · Chief Administrative Officer
Mark A. Kronenfeld · Director
Roy Winston · Chief Medical Officer
David M Stack · CEO and Chair
Jonathan Slonin · Chief Clinical Officer
Charles A. Reinhart III · CFO
Max Reinhardt · Pres, Rest of World
Anthony Molloy · Chief Lgl, Compliance Officer
Dennis Mcloughlin · Chief Customer Officer
Daryl Gaugler · COO
Ronald J. Ellis Jr. · Chief Strategy Officer
Lauren Bullaro Riker · SVP, Finance
Kristen Marie Williams · Chief Administrative Officer
Daryl Gaugler · COO
Paul J Hastings · Director
Gary W Pace · Director
Laura Brege · Director
Anthony Molloy · Chief Lgl, Compliance Officer
Max Reinhardt · Pres, Rest of World
Roy Winston · Chief Medical Officer
Paul J Hastings · Director
Jonathan Slonin · Chief Clinical Officer
David M Stack · CEO and Chair
Roy Winston · Chief Medical Officer
Charles A. Reinhart III · CFO
Max Reinhardt · Pres, Rest of World
Charles Anthony Laranjeira · Chief Technical Officer
Anthony Molloy · Chief Lgl, Compliance Officer
Dennis Mcloughlin · Chief Customer Officer
Daryl Gaugler · COO
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.